![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ViralClear to Test Antiviral Merimepodib for Advanced COVID-19
ViralClear to Test Antiviral Merimepodib for Advanced COVID-19
![COVID-19](https://www.fdanews.com/ext/resources/test/Drug-Images4/COVID-19-image.gif?t=1615503643&width=430)
The FDA has approved ViralClear Pharmaceuticals’ application for a phase 2 study of its antiviral merimepodib as a possible COVID-19 treatment.
The trial will evaluate the oral antiviral in hospitalized COVID-19 patients who require supplemental oxygen or are on non-invasive ventilation or high-flow oxygen devices.
Merimepodib was previously being developed by Vertex Pharmaceuticals for chronic hepatitis C and psoriasis.
Upcoming Events
-
18Jul
-
21Oct